Ready to Ship!

Empagliflozin Tablets 10mg (Pingxinda) – For Research Use Only

2 Reviews

-54%
2 Reviews
✖ CURRENTLY OUT OF STOCK
Your Perfect Ride Awaits
  • Free Home delivery available
  • Friendly customer support
  • Best pricing for you
  • COD available
  • Easy EMI
Guaranteed Safe Checkout

Request a Call Back
DescriptionEmpagliflozin Tablets 10mg, marketed under the name Pingxinda, are designed for experimental use in laboratory settings to support studies involving glucose regulation, SGLT2 inhibition, and type 2 diabetes mellitus (T2DM). These tablets inhibit sodium-glucose co-transporter 2 (SGLT2) in renal proximal tubules, resulting in reduced reabsorption of glucose and increased urinary glucose excretion in research models.Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., this product is approved under H20234642 and adheres to GMP production standards.?? For laboratory research use only. Not for human use. Contents hide 1 Product Parameters 2 Mechanism & Research Applications 3 Observed Effects in Research 4 Safety & Handling 5 Research Use Disclaimer Product ParametersAttributeDetailsProduct NameEmpagliflozin TabletsBrand NamePingxinda (???)CAS Number864070-44-0Molecular FormulaC23H27ClO7Strength10mgDosage FormTabletsSpecification10 tablets per boxApproval NumberH20234642Product Code86905847001015ManufacturerQilu Pharmaceutical (Hainan) Co., Ltd.Package UnitBoxIntended UseResearch onlyBarcode6949384101351Mechanism & Research ApplicationsEmpagliflozin is a selective SGLT2 inhibitor. It blocks the reabsorption of glucose in the kidney, leading to increased urinary glucose excretion. In preclinical research, this helps simulate conditions similar to those found in patients with type 2 diabetes.Research applications include:Investigating glucose metabolism pathwaysStudying renal sodium-glucose co-transport inhibitionModeling T2DM therapies in vitro or in vivoTesting combinatorial therapies with metformin or DPP-4 inhibitorsObserved Effects in ResearchReduced fasting and postprandial blood glucose in test modelsIncreased urinary glucose outputWeight loss and improved insulin sensitivity in rodentsReduced systolic blood pressure markersDelayed progression of diabetic kidney disease in long-term studiesSafety & HandlingResearch Grade Only – Not for clinical, diagnostic, or human useStorage – Store below 25°C in a dry, light-protected environmentHandling – Use PPE: gloves, lab coat, eye protectionShelf Life – Refer to packaging or Certificate of AnalysisDisposal – Follow institutional guidelines for chemical disposalResearch Use DisclaimerThis product is intended strictly for laboratory research use only. It is not for human or veterinary use, not a drug, and should only be handled by trained professionals.

Specifications

×

Submit Your Details

Thank You!

We've received your details. We will notify you once stock is back.

Let us help you find the perfect wheelchair for your needs!

Share your name and email for a quick callback.

Model Ryder 1 Pro F16
 Frame Style Foldable
 Frame Material  MS
 Out to Out Width In open   Position  24"
 Seat Width 18"
 Total Width in Closing   Position 10"
 Rear Wheel Size 16"
 Front Wheel Size 6"
 Seat to Floor Height In 19"
 Seat Depth 15"
 Back height 14"
 Total Height 33"
 Total Length 32"
Armrest Height from seat 8"
 Max user Weight Capacity 100 Kg
 Net Weight 10.2 KG
Gross Weight 11.5 KG
 Upholstery Nylon
 Armrest PVC Plastic
 Footrest PVC Plastic
 Wheel Quality Mag 
 Rear Wheel Lock Yes
 Hand Brakes Yes
Foldable Backrest N/A
 Wheel Type Solid